Delivery Order SPE2DB20D3103-SPE2DB22FQ0D8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,253.54 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of July 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The $2,184.04 firm fixed price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The contract, valued at $4,001.24, is a firm fixed price delivery order that does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The $5,456.23 firm fixed-price delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,804.74, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant...
- This federal contract award, valued at $15,307.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for Trelegy Ellipta 200-62.5-25 60S, a prescription medication, with a completion date of June 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 200-62.5-25 60S medication. The $5,611.18 firm fixed-price delivery order has a completion date of May 6, 2022. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, valued at $8,528.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. There was no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FQ0D8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Trelegy Ellipta 100-62.5-25 60s medication. The firm-fixed-price delivery order, valued at $2,316.54, has an ultimate completion date of September 27, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/26/22 |